Female Viagra
Female Viagra
- In our pharmacy, you can buy “Female Viagra” (flibanserin and bremelanotide) with a prescription in the United States, while sildenafil-based products may be available over the counter in some countries like India.
- “Female Viagra” is used to treat hypoactive sexual desire disorder (HSDD) in premenopaCanadal women. Flibanserin works as a selective serotonin 1A receptor agonist and a 5-HT2A receptor antagonist, while bremelanotide is a melanocortin receptor agonist.
- The usual dosage of flibanserin is 100 mg taken orally at bedtime, and for bremelanotide, it is 1.75 mg administered as a subcutaneous injection before sexual activity.
- The forms of administration are oral tablets for flibanserin and a subcutaneous injection for bremelanotide.
- The effect of flibanserin begins within 4 to 8 weeks, while bremelanotide can start working within 45 minutes before sexual activity.
- The duration of action for flibanserin is continuous with nightly dosing; for bremelanotide, it is a maximum of 1 dose every 24 hours, not to exceed 8 doses per month.
- Do not consume alcohol while taking flibanserin, as it may increase the risk of severe hypotension and syncope.
- The most common side effects include dizziness, somnolence, and nausea for flibanserin, and nausea and flushing for bremelanotide.
- Would you like to try “Female Viagra” without a prescription?
Basic Female Viagra Information
- INN (International Nonproprietary Name)
- Brand names available in Canada
- ATC Code
- Forms & dosages (e.g., tablets, injections, creams)
- Manufacturers in Canada
- Registration status in Canada
- OTC / Rx classification
INN And Brand Names In Canada
The term "Female Viagra" typically refers to flibanserin (Addyi) and bremelanotide (Vyleesi). These two medications are used to address hypoactive sexual desire disorder (HSDD) in premenopausal women. HSDD can involve a lack of sexual desire, causing distress and discomfort in personal relationships.
ATC Code And Dosage Forms
Flibanserin is classified under the ATC code G02CX01, while bremelanotide falls under the code G02CX06. Flibanserin is available as a film-coated oral tablet, typically dosed at 100 mg and taken once daily at bedtime. On the other hand, bremelanotide is a subcutaneous injection, provided in a pre-filled autoinjector with a dose of 1.75 mg per injection, to be used as needed up to eight times per month.
Manufacturers And Registration Status
Both Addyi and Vyleesi are manufactured by Sprout Pharmaceuticals and AMAG Pharmaceuticals, respectively. In Canada, flibanserin is not currently approved for sale, while bremelanotide does hold approval, allowing for its prescription in the treatment of HSDD. This differs from the regulations in the EU, where flibanserin has not seen approval as of the latest updates.
OTC / Rx Classification
In Canada, both Addyi and Vyleesi are classified as prescription medications, meaning they require a valid prescription from a healthcare provider to obtain them. This is vital for ensuring safe usage under professional guidance, considering the complexities surrounding female sexual health.
Dosage & Administration
When considering the right treatment for hypoactive sexual desire disorder (HSDD), understanding the appropriate dosages is crucial. For flibanserin, commonly referred to as "Female Viagra," the standard dosage is 100 mg taken orally at bedtime. This helps in maintaining consistent blood levels.
For bremelanotide, marketed as Vyleesi, the typical dosage is 1.75 mg administered as a subcutaneous injection at least 45 minutes before anticipated sexual activity, with a maximum of one dose in a 24-hour period. Up to eight doses per month are allowed.
Special care should be given to certain patient populations. The elderly and those with liver or kidney impairment may require dosage adjustments. Flibanserin, for example, is contraindicated in individuals with severe liver impairment. Similarly, bremelanotide should be used cautiously in those with liver or renal issues.
Treatment duration varies significantly between these medications. Flibanserin is typically prescribed for continuous nightly use, reassessing benefits at eight-week intervals. In contrast, Vyleesi is used on an as-needed basis.
Proper medication storage is vital. Flibanserin should be stored at room temperature, away from moisture. Vyleesi requires protection from light and heat, also staying at room temperature.
Safety & Warnings
Before embarking on treatment, knowing the warnings associated with flibanserin and bremelanotide is essential. Absolute contraindications for flibanserin include severe liver disease and concurrent alcohol consumption, which heightens risks of hypotension and syncope. Similarly, bremelanotide has contraindications, especially for those with hypersensitivity to its active ingredients.
Relative contraindications are also noteworthy. Patients with moderate hepatic or renal impairment should be monitored closely while on these medications. Additionally, drinking alcohol can lead to risks associated with both drugs, particularly flibanserin.
| Common Side Effects | Severe Side Effects |
|---|---|
| Dizziness | Hypotension |
| Nausea | Syncope |
| Fatigue | Allergic reactions |
Furthermore, flibanserin has a black box warning due to its potential for severe adverse effects, underscoring the importance of managing dosage and patient selection with thoroughness.
Patient Experience
User feedback can provide valuable insights into the medications' effectiveness and tolerability. Reviews collected from sites like Drugs.com reveal a wide range of experiences with flibanserin and bremelanotide. While some users note significant improvements in their sexual desire and satisfaction, others report dissatisfaction due to side effects or lack of effectiveness.
Common themes from forums such as Facebook and TPU highlight variability in experiences. Many users emphasize the importance of setting realistic expectations regarding results. For instance, side effects such as dizziness and nausea are mentioned frequently, indicating the need for proper patient counseling.
The perceived effectiveness of these medications can vary considerably, influenced by individual health backgrounds and co-morbid conditions. While flibanserin users often report a gradual increase in desire, bremelanotide’s on-demand nature leads to differing experiences around its use before sexual activity.
Alternatives & Comparison
For those seeking alternatives to flibanserin and bremelanotide in Canada, options such as herbal supplements and other prescription drugs may be available. Popular alternatives include Ginseng and Maca root, often touted for their libido-enhancing properties. Consult local pharmacies for potential options and effectiveness.
| Alternative | Price | Effectiveness | Safety | Availability |
|---|---|---|---|---|
| Ginseng | Varies | Moderate | Generally safe | OTC |
| Maca | Varies | Moderate | Generally safe | OTC |
| Prescription Options | Varies | Specific to condition | Monitor for interactions | Rx required |
Local practitioners often recommend a thorough evaluation of health and lifestyle before deciding on alternatives. This ensures the chosen treatment aligns with patient needs and medical history.
Market Overview (Canada)
Medications known as "Female Viagra," specifically flibanserin (Addyi) and bremelanotide (Vyleesi), play a critical role in addressing hypoactive sexual desire disorder (HSDD) in women. These medications can be readily found at pharmacies such as Catena and HelpNet, where healthcare professionals can provide guidance tailored to a patient’s needs.
When discussing the cost of these medications, prices for flibanserin typically range from $400 to $600 for a month’s supply, while bremelanotide can cost around $500 for an 8-dose treatment. These prices can vary based on insurance coverage, pharmacy location, and any available patient assistance programs.
Packaging for flibanserin often comes in blister packs, containing a 30-day supply of 100 mg film-coated tablets. Bremelanotide, on the other hand, is usually available in a pre-filled autoinjector format, designed for single-use injections of 1.75 mg, making it user-friendly for in-home administration.
Looking at demand patterns, it's clear that interest in these products has increased, significantly influenced by the COVID-19 pandemic. Many women have sought solutions for HSDD during lockdowns, seeking ways to enhance their sexual health and overall quality of life.
Research & Trends
The landscape of research surrounding flibanserin and bremelanotide has been eye-opening. Recent studies from 2022 to 2025 have reinforced their efficacy, with several meta-analyses and clinical trials demonstrating positive outcomes for women experiencing HSDD. These findings underline the importance of these medications as viable options for those struggling with low sexual desire.
Beyond their approved uses, flibanserin and bremelanotide are being explored for application in sexual health contexts like women experiencing post-menopausal low libido. As healthcare professionals look for alternatives, interest in experimental uses continues to grow.
The patent status of flibanserin is set to expire in the coming years, which raises the possibility for generic versions to enter the market, potentially improving accessibility and lowering prices for women’s health products. As more generics become available, the competition may help to normalize prices in the market for female Viagra in Canada.
Guidelines for Proper Use
Understanding the proper use of flibanserin and bremelanotide is crucial for achieving the best results. Flibanserin is recommended to be taken once daily at bedtime, as taking it at another time could increase the likelihood of side effects. Bremelanotide can be administered as needed, at least 45 minutes before anticipated sexual activity, ensuring its effectiveness without the risk of overuse.
Importantly, both medications have specific interactions to watch out for, especially with alcohol. Drinking alcohol while on flibanserin can amplify the side effects, like dizziness or moments of low blood pressure. Hence, avoiding alcohol is essential to mitigate risks.
For storage, keep flibanserin at room temperature, away from moisture, while bremelanotide should be protected from light and stored similarly at room temperature. To ensure safety, patients should avoid common pitfalls like missing doses or consuming alcohol when taking flibanserin.
It's always advised to read the accompanying patient leaflets carefully and consult healthcare providers for personalized advice. Knowledge about these medications and how to use them effectively can greatly empower women in enhancing their sexual health.